Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study
- 1 May 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 351 (9115) , 1535-1539
- https://doi.org/10.1016/s0140-6736(98)07236-5
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?Hepatology, 1996
- Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosisJournal of Hepatology, 1996
- Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core proteinVirus Research, 1995
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patientsHepatology, 1995
- Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: Relative risk and population attributable risk from a case-control study in ItalyJournal of Hepatology, 1992
- Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosisJournal of Hepatology, 1991
- Transforming Growth Factors β1 and α in Chronic Liver DiseaseNew England Journal of Medicine, 1991
- PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMAThe Lancet, 1989
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981